A Randomized, Double-blind, Placebo-controlled, Dose Ranging, Parallel, Multi-Centre, Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects with Moderate to Severe Submental Fat.
来源：PubMed发布日期：2026-07-05作者：Lee SH, Lee WS, Shin MK, Lew BL, Lee SE0 次点击